Hypertension Research
Online ISSN : 1348-4214
Print ISSN : 0916-9636
ISSN-L : 0916-9636
Arginine Vasopressin Inhibits Nitric Oxide Synthesis in Cytokine-Stimulated Vascular Smooth Muscle Cells
Keiji YamamotoUichi IkedaKoji OkadaToshikazu SaitoKazuyuki Shimada
著者情報
ジャーナル フリー

1997 年 20 巻 3 号 p. 209-216

詳細
抄録

The purpose of this study was to investigate the effects of arginine vasopressin (AVP) on nitric oxide (NO) synthesis in vascular smooth muscle cells (VSMCs). We measured the production of nitrite, a stable metabolite of NO, and the expression of inducible NO synthase (iNOS) mRNA in cultured rat VSMCs. Incubation of VSMCs for 24h with interleukin-1β (IL-1β) caused a significant increase in NO production. Both AVP and the V1a receptor agonist [Phe2, Ile3, Orn8]vasopressin inhibited NO synthesis in IL-1β-stimulated cells, but not in unstimulated cells, in a dose-dependent manner. The V1a receptor antagonist [d(CH2)51, O-Me-Tyr2, Arg8]vasopressin completely inhibited the effect of AVP. Incubation with IL-1β for 24h induced the expression of iNOS mRNA in VSMCs, while AVP suppressed its expression. After functional depletion of protein kinase C activity by treating cells with phorbol 12-myristate 13-acetate for 24h, AVP did not inhibit IL-1β-induced NO production. The effect of AVP was also inhibited in the presence of the protein kinase C inhibitor calphostin C in a dose-dependent manner. These results indicate that AVP inhibits IL-1β-induced iNOS expression in VSMCs through the V1a receptor, which is mediated at least partially via activation of protein kinase C. (Hypertens Res 1997; 20: 209-216)

著者関連情報
© The Japanese Society of Hypertension
前の記事 次の記事
feedback
Top